Table 2 Patient characteristics according to intensity of TF expression in cancer tissues

From: Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer

 

Intensity of TF expression

 
 

(−) n =5

(+) n =9

(++) n =10

(+++) n =8

P

(mean ± s.d.)

 Age (years)

51.0 ± 8.1

48.8 ± 10.2

55.6 ± 14.4

42.9 ± 17.3

0.4407

 BMI

25.0 ± 3.2

24.7 ± 6.1

22.7 ± 3.6

21.5 ± 1.9

0.0796

 D-dimer (μg ml−1)

1.50 ± 0.93

1.55 ± 1.06

5.28 ± 3.85

10.4 ± 9.94

0.0030

Neoadjuvant chemotherapy (number of subjects)

 (+) (n=15)

3

4

6

2

0.3387

FIGO stage (number of subjects)

 Stage I (n=7)

1

2

2

2

0.8034

 Stage II (n=6)

1

1

2

2

 

 StageIII (n=11)

1

4

3

3

 

 Stage IV (n=8)

2

2

3

1

 

Histological classification (number of subjects)

 Non-clear cell

4

8

6

3

0.0391

 Clear cell

1

1

4

5

 
  1. A significant correlation existed between TF expression and D-dimer concentration (P=0.003; ρ=0.533). Tissue from clear cell carcinoma showed significantly stronger TF expression than tissue from non-clear cell carcinoma (P<0.05).
  2. BMI=body mass index; FIGO=International Federation of Gynecology and Obstetrics; TF=tissue factor.
Back to article page